Protalix BioTherapeutics Reports Third Quarter 2022 Financial and Business Results
- Monday, November 14, 2022, 7:10
- PR Newswire
- Add a comment
Company to host conference call and webcast today at 8:30 a.m. EST CARMIEL, Israel, Nov. 14, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant…
About the Author
admin has written 21725 stories on this site.